ETN
64
3
EXPE
77
2
EBAY
47
2
PLD
35
-2
CCL
60
2
PHM
48
-4
CHD
42
-6
CLX
55
2
LOW
55
2
PPL
82
-2
EW
46
2
GLW
53
3
PDCO
71
2
PG
64
4
OKE
58
3
VTR
55
-2
AMAT
52
2
BBY
48
3
NWSA
78
3
SLB
44
2
ETN
64
3
EXPE
77
2
EBAY
47
2
PLD
35
-2
CCL
60
2
PHM
48
-4
CHD
42
-6
CLX
55
2
LOW
55
2
PPL
82
-2
EW
46
2
GLW
53
3
PDCO
71
2
PG
64
4
OKE
58
3
VTR
55
-2
AMAT
52
2
BBY
48
3
NWSA
78
3
SLB
44
2
Financhill
Back

Matinas BioPharma Holdings Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
38

MTNB
Matinas BioPharma Holdings

Last Price:
$0.63
Seasonality Move:
-18.9%
Buy
63

RYTM
Rhythm Pharmaceuticals

Last Price:
$63.69
Seasonality Move:
15.42%
Sell
38
Matinas BioPharma Holdings (MTNB) is a Sell

Is Matinas BioPharma Holdings a Buy, Sell or Hold?

  • The current Matinas BioPharma Holdings [MTNB] share price is $0.67. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MTNB Stock Price Chart

What is Matinas BioPharma Holdings's stock price today?

  • The Matinas BioPharma Holdings share price today is $0.67
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $63.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

MTNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 64.51 Buy
Chaikin Money Flow: 112759 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 0.6) Buy
Bollinger Bands (100): (0.52 - 0.64) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 63.66 Buy
Chaikin Money Flow: 369446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.02 - 61.16) Buy
Bollinger Bands (100): (53.03 - 59.91) Buy

MTNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.59 Buy
20-day SMA: 0.56 Buy
50-day SMA: 0.57 Buy
200-day SMA: 2.48 Sell
8-day EMA: 0.6 Buy
20-day EMA: 0.58 Buy
50-day EMA: 0.6 Buy
200-day EMA: 2.77 Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.43 Buy
20-day SMA: 57.42 Buy
50-day SMA: 55.27 Buy
200-day SMA: 53.46 Buy
8-day EMA: 61.16 Buy
20-day EMA: 58.64 Buy
50-day EMA: 56.64 Buy
200-day EMA: 52.62 Buy

Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.

Matinas BioPharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):